Design and Validation of Novel Potential Antiperspirant Peptides Blocking M3-Gαq Sweat Signaling Cascade

No abstract is available for this paper.

• Publication year

  2024

• Venue

  International Journal of Peptide Research and Therapeutics

• Publication date

  2024-07-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s10989-024-10628-4
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Design and validation of neuronal exocytosis blocking peptides as potential novel antiperspirants

  2023cited by this paper
• Lipidization as a tool toward peptide therapeutics

  2023cited by this paper
• The pharmacological treatment and management of hyperhidrosis

  2022cited by this paper
• Aluminium in cosmetics and personal care products

  2021cited by this paper
• Reduction of focal sweating by lipid nanoparticle-delivered myricetin

  2020cited by this paper
• Glycopyrronium Tosylate (Qbrexza) for Hyperhidrosis

  2019cited by this paper
• Topical Treatment of Primary Focal Hyperhidrosis, Part 1.

  2019cited by this paper
• Understanding G Protein Selectivity of Muscarinic Acetylcholine Receptors Using Computational Methods

  2019cited by this paper
• The Etiology, Diagnosis and Management of Hyperhidrosis: A Comprehensive Review. Part II. Therapeutic Options.

  2019cited by this paper
• Hyperhidrosis and its impact on those living with it.

  2018cited by this paper
• Neural control of sweat secretion: a review

  2018cited by this paper
• Oxybutynin 3% gel for the treatment of primary focal hyperhidrosis in adolescents and young adults

  2018cited by this paper
• Safety of available and emerging drug therapies for hyperhidrosis

  2017cited by this paper
• Treatment of primary hyperhidrosis with oral anticholinergic medications: a systematic review

  2017cited by this paper
• Regulation and trafficking of muscarinic acetylcholine receptors.

  2017cited by this paper
• Oral medications.

  2014cited by this paper
• Managing hyperhidrosis: emerging therapies.

  2014cited by this paper
• Topical glycopyrrolate for axillary hyperhidrosis

  2013cited by this paper
• Dilated pupils caused by topical glycopyrrolate for hyperhidrosis

  2007cited by this paper
• Estimation of Agonist Activity at G Protein-Coupled Receptors: Analysis of M2 Muscarinic Receptor Signaling through Gi/o,Gs, and G15

  2007cited by this paper
• Muscarinic M2 Receptors Directly Activate Gq/11 and Gs G-Proteins

  2007cited by this paper
• Topical atropine sulfate for the treatment of axillary hyperhidrosis

  2006cited by this paper
• Muscarinic M3 receptor coupling and regulation.

  1997cited by this paper
• Muscarinic M3 receptors mediate secretion from sweat glands in the rat.

  1991cited by this paper
• Structural changes in axillary eccrine glands following long‐term treatment with aluminium chloride hexahydrate solution

  1984cited by this paper

• No citing papers are available for this paper.